Anti-Mllerian hormone (AMH) is a glycoprotein produced by granulosa cells in ovarian follicles. Strategies to elevate AMH levels are often sought, particularly in the context of fertility and reproductive health management. While directly manipulating hormone concentration can be complex, supportive approaches may be considered.
Maintaining sufficient levels of this hormone is generally associated with a larger ovarian reserve, offering a potential advantage for individuals planning future pregnancies. Understanding the factors that influence reproductive health can be crucial in making informed decisions regarding fertility preservation and treatment options. Historically, research into ovarian reserve markers has advanced significantly, providing clinicians with more sophisticated tools for assessing reproductive potential.
